Galip Can Uyar: Access to Healthcare Can Be a Powerful Determinant of Patient Outcomes - Oncodaily

Galip Can Uyar: ‘Melanoma and Other Skin Cancers’ Congress Highlights – ESMO2025 - Oncodaily

Galip Can Uyar: A Perfect Convergence of Innovation at ESMO 2025 - Oncodaily

Galip Can Uyar: An Important Step Toward the Distinct Biology and Management of Early-Onset BTC - Oncodaily

Mother of Fatma Uyar killed in Silopi: Everyone must take responsibility - ANF

Galip Can Uyar: Ficorella et al. Show BOADICEA Boosts Breast Cancer Risk Prediction - Oncodaily

Galip Can Uyar: Integrating Psychosocial Competencies into Oncology Fellowship Training - Oncodaily

Galip Can Uyar Highlighted the JCOG1314 (MIRACLE) Study on Metastatic Esophageal Cancer - Oncodaily

Galip Can Uyar: Can AI Predict Cancer Recurrence Before It Happens? - Oncodaily

Galip Can Uyar: Can Metformin Improve Outcomes in Metastatic Hormone-sensitive Prostate Cancer? - Oncodaily

Galip Can Uyar: Can Early Multidisciplinary Interventions Reduce Immune-Related Skin Toxicities in NSCLC? - Oncodaily

Galip Can Uyar: Givastomig plus Nivolumab plus mFOLFOX in Metastatic GEC (Phase I/II) - Oncodaily

Galip Can Uyar: The Phase 3 CONTACT-02 Trial - Oncodaily

Galip Can Uyar: Can Survivor Stories Heal Distress? - Oncodaily

Galip Can Uyar: Ovarian Cancer Treatment Is Entering a New Era - Oncodaily